BioSpace News Archive

Policy

Eight government initiatives compete to win ‘Flag’ of the Hamdan Bin Mohammed Programme for Smart Government

Eight initiatives shortlisted from 33 initiatives presented by 24 government entities

November 14, 2018
·
3 min read
Novel antibacterial drugs developed at University of Eastern Finland

Researchers at the University of Eastern Finland have developed novel antibacterial compounds, focusing on the role of LsrK kinase. LsrK kinase is a protein involved in bacterial communication.

November 14, 2018
·
3 min read
MorphoSys to Present Data on Investigational Drugs MOR208 and MOR202 in Various Blood Cancer Indications at ASH 2018 Meeting

MOR208 (L-MIND): Interim data from phase 2 L-MIND study of MOR208 plus lenalidomide in 81 patients with relapsed/refractory DLBCL accepted for oral presentation

November 14, 2018
·
7 min read
Drug Development

Aptinyx Completes Enrollment in Phase 2 Study of NYX-2925 for Painful Diabetic Peripheral Neuropathy

Top-line Data Expected Early in the First Quarter of 2019

November 14, 2018
·
5 min read
Business

Retrophin Reports Third Quarter 2018 Financial Results

Pivotal programs enrolling towards first data readout in 2019

November 14, 2018
·
17 min read
Genetown

Syndax Pharmaceuticals Announces Presentations at the 60th American Society of Hematology Annual Meeting

Syndax Pharmaceuticals, Inc. today announced that the Company’s Menin-MLLr program will be featured during two presentations at the 60th American Society of Hematology (ASH) Annual Meeting being held December 1-4, 2018 in San Diego, California.

November 14, 2018
·
4 min read
Policy

Lamellar Biomedical Submits Patent for LAMELLASOME™ platform for the safe and effective delivery of nucleic acid based therapeutics

Unique technology set to play a key role in the rapidly emerging gene therapy market

November 14, 2018
·
4 min read
Genetown

SQZ Biotech Announces PNAS Publication Demonstrating Significant Advantages of Its Cell Squeezing Technology for the Development of Cell-Based Therapeutics

New Data Highlight the Superiority of the SQZ Platform in Preserving Cellular Functions for Cell Therapy Applicat

November 14, 2018
·
3 min read
HAWAII BIOTECH AWARDED $38.5 MILLION FOR CONTINUED DEVELOPMENT OF ANTI-TOXIN DRUG TO TREAT ANTHRAX IN HUMANS

Hawaii Biotech Inc. will continue its development of an anti-toxin drug for anthrax in humans with a recently awarded contract from the National Institute of Allergy and Infectious Diseases (NIAID), a federal government agency.

November 14, 2018
·
2 min read
Policy

BREAST CANCER’S DEADLINESS IS INFLUENCED BY OUR GENES

An international team of scientists have confirmed that both rare and common mutations of our genes are linked to the development of breast cancer, including tumour characteristics and corresponding deadliness.

November 14, 2018
·
4 min read